Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlling Uveitis with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The design, synthesis, and characterization of potent and selective MEK7 inhibitors as targeted therapies for T-cell acute lymphoblastic leukemia
A FOXP3 complex that controls human regulatory T cell function
Elucidating and targeting the molecular foundations of IDH mutant glioma
Bio-optical and Bio-electronic Materials for Real-time Analyte Detection
Cofactor for TYPE-1 Plasminogen Activator Inhibitor
Recently added grants:
Forespore engulfment during B. subtilis sporulation
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease
Understanding the functions of USH2A and ADGRV1 in photoreceptors by identifying their interacting proteins
Statistical Methods for RNA-seq Data Analysis
Advanced Computational Approaches for NMR Data-mining
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011050-01A1
Application #
2165303
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1996-05-01
Project End
1996-10-31
Budget Start
1996-05-01
Budget End
1996-10-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant